|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, March 19, 2019 ) In order to dissert the market scenario prevailing across the “prefilled syringes market” sector, FactMR has evenly presented a new examination titled “Global Prefilled Syringes Market Expected to Deliver Dynamic Progression until 2026”, to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the “prefilled syringes market” in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable.
Get Sample PDF Illustration Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=603
According to research on prefilled syringes by FactMR, the global market for prefilled syringes is expected to expand at a value CAGR of 9.6% during the period of forecast, 2017-2026. By end of 2026, more than 10,200,000 thousand units of prefilled syringes are expected to be sold across the globe in various healthcare facilities. Key companies involved in the global prefilled syringes market include Becton Dickinson and Company, Terumo Medical Corporation, Baxter International Inc., Medtronic and Gerresheimer. Success of biologic drugs, owing to their capability to treat chronic diseases, has taken the pharmaceutical industry to a new level. Biologics, offering enhanced curing abilities without side effects are being widely used to treat chronic ailments such as cancer and other autoimmune diseases. With FDA approval, several companies have been introducing novel biologic drugs for various therapeutic areas. This has made delivery of biologics an important aspect.
With growing innovations in drug delivery systems, for instance adoption of prefilled syringes, the administration of biologics has been convenient and effective. Novel drug delivery systems such as prefilled syringes have gained high traction as effective delivery systems especially for injectable drugs. Moreover, prefilled syringes are aiding in delivery of personalized drugs specifically tailored for small patient populations.
Prefilled syringes come in two types of material, namely plastic and glass. Glass prefilled syringes are a widely used drug injectable system for parenteral drugs owing to its compatible features, for instance, higher stability, oxygen permeability and non-reactive nature. However, the main challenge of glass prefilled syringes is their fragile nature. Glass prefilled syringes require high caution while storing or transportation, in the absence of which, loss of injectable drugs can take place. On the other hand, plastic prefilled syringes are also witnessing increased demand, with introduction of advanced plastic material that removes the chances of reaction of drug with inner walls of the syringe, thereby maintaining the pH level of the medicine.
Use of advanced polymer material, for instance, crystal-clear polymer and polypropylene, have increased the adoption of plastic prefilled syringes. These advanced plastic material being biocompatible, do not initiate chemical activity within the syringe. Moreover, chance of breakage is removed with the use of plastic prefilled syringes. However, majority of prefilled syringes are made of glass, and sales of glass prefilled syringes are expected to sky rocket in the coming years.
Browse Complete Report Here – https://www.factmr.com/report/603/prefilled-syringes-market
According to Prefilled Syringes West Coast Conference held in 2017, the use of prefilled syringes in North America have gained high demand with increasing need for safety, patient satisfaction and high quality. Counters in North America, especially the United States, are reflecting higher expenditure on injectable drug delivery systems, for instance development of composite polymer prefilled syringes. These syringes have high break resistance. In addition the needle is attached with use of insert molding procedure, thus eliminating the use of tungsten and glue, increasing their sterilization levels.
The prevalence of chronic diseases in United States and Canada, according to analysis of American Heart Association, is increasing owing to increased use of tobacco and smoking. This has made it imperative for pharmaceutical companies in this region to develop novel biologics to fight against chronic disorders such as cancer. This is expected to fuel the adoption of efficient drug delivery systems such as prefilled syringes in the coming years.
To Purchase this Report, Click here - https://www.factmr.com/checkout/603/S
About FactMr
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Fact.MR
James Hilton
+353-1-6111-593
info@factmr.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
